Summit Securities Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $899K | Buy |
|
|||||
|
2024
Q4 | $37K | Sell |
|
|||||
|
2024
Q3 | $343K | Sell |
|
|||||
|
2024
Q2 | $1.63M | Buy |
|
|||||
|
2024
Q1 | $93K | Sell |
|
|||||
|
2023
Q4 | $2.72M | Buy |
|
|||||
|
2023
Q3 | $38K | Sell |
|
|||||
|
2023
Q2 | $5.22M | Sell |
|
|||||
|
2023
Q1 | $5.76M | Buy |
|
|||||
|
2022
Q4 | $75K | Sell |
|
|||||
|
2022
Q3 | $141K | Buy |
|
|||||
|
2022
Q2 | $7K | Sell |
|
|||||
|
2022
Q1 | $255K | Sell |
|
|||||
|
2021
Q4 | $338K | Hold |
|
|||||
|
2021
Q3 | $348K | Sell |
|
|||||
|
2021
Q2 | $1.34M | Sell |
|
|||||
|
2021
Q1 | $1.48M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $225K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.04M | Sell |
|
|||||
|
2019
Q3 | $936K | Sell |
|
|||||
|
2019
Q2 | $916K | Sell |
|
|||||
|
2019
Q1 | $1.41M | Buy |
|
|||||
|
2018
Q4 | $722K | Sell |
|
|||||
|
2018
Q3 | $795K | Sell |
|
|||||
|
2018
Q2 | $1.31M | Sell |
|
|||||
|
2018
Q1 | $1.34M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $213K | Buy |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $86K | Sell |
|
|||||
|
2015
Q2 | $102K | Sell |
|
|||||
|
2015
Q1 | $171K | Buy |
|
|||||
|
2014
Q4 | $106K | Sell |
|
|||||
|
2014
Q3 | $114K | Buy |
|
|||||
|
2014
Q2 | $89K | Sell |
|
|||||
|
2014
Q1 | $117K | Buy |
|
|||||
|
2013
Q4 | $30K | Sell |
|
|||||
|
2013
Q3 | $83K | Buy |
|
|||||
|
2013
Q2 | $47K | Buy |
|